A detailed history of Advisor Group Holdings, Inc. transactions in Novavax Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 37,115 shares of NVAX stock, worth $319,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,115
Previous 34,131 8.74%
Holding current value
$319,931
Previous $432,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.71 - $17.11 $31,958 - $51,056
2,984 Added 8.74%
37,115 $468,000
Q2 2024

Aug 13, 2024

SELL
$3.89 - $20.97 $162,446 - $875,707
-41,760 Reduced 55.03%
34,131 $432,000
Q1 2024

May 10, 2024

SELL
$3.76 - $6.02 $17,461 - $27,956
-4,644 Reduced 5.77%
75,891 $362,000
Q4 2023

Feb 12, 2024

SELL
$4.8 - $7.67 $28,459 - $45,475
-5,929 Reduced 6.86%
80,535 $386,000
Q3 2023

Nov 13, 2023

BUY
$6.81 - $9.74 $73,772 - $105,513
10,833 Added 14.32%
86,464 $625,000
Q2 2023

Aug 10, 2023

BUY
$6.67 - $9.52 $78,852 - $112,545
11,822 Added 18.53%
75,631 $561,000
Q1 2023

May 12, 2023

BUY
$5.76 - $12.48 $44,755 - $96,969
7,770 Added 13.87%
63,809 $442,000
Q4 2022

Feb 10, 2023

BUY
$8.86 - $25.04 $68,638 - $193,984
7,747 Added 16.04%
56,039 $576,000
Q3 2022

Nov 14, 2022

SELL
$18.2 - $76.12 $85,103 - $355,937
-4,676 Reduced 8.83%
48,292 $878,000
Q2 2022

Aug 10, 2022

SELL
$36.28 - $75.29 $640,813 - $1.33 Million
-17,663 Reduced 25.01%
52,968 $2.73 Million
Q1 2022

May 04, 2022

BUY
$69.73 - $142.9 $1.49 Million - $3.05 Million
21,362 Added 43.36%
70,631 $5.08 Million
Q3 2021

Nov 05, 2021

BUY
$177.8 - $270.58 $637,590 - $970,299
3,586 Added 7.85%
49,269 $10.2 Million
Q2 2021

Aug 02, 2021

SELL
$121.0 - $257.67 $226,996 - $483,388
-1,876 Reduced 3.94%
45,683 $9.7 Million
Q1 2021

May 13, 2021

SELL
$112.98 - $319.93 $524,566 - $1.49 Million
-4,643 Reduced 8.89%
47,559 $8.63 Million
Q4 2020

Feb 10, 2021

BUY
$78.74 - $139.5 $1.53 Million - $2.71 Million
19,444 Added 59.36%
52,202 $5.82 Million
Q3 2020

Nov 12, 2020

BUY
$79.44 - $178.51 $6,990 - $15,708
88 Added 0.27%
32,758 $3.49 Million
Q2 2020

Aug 14, 2020

SELL
$13.86 - $83.61 $241,912 - $1.46 Million
-17,454 Reduced 34.82%
32,670 $2.72 Million
Q1 2020

May 18, 2020

BUY
$3.93 - $16.0 $196,987 - $801,984
50,124 New
50,124 $687,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $674M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.